B3GNT5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.437800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.826600E-01
Normal-vs-Stage2
2.046200E-01
Normal-vs-Stage3
8.401600E-01
Normal-vs-Stage4
2.383600E-01
Stage1-vs-Stage2
4.037200E-01
Stage1-vs-Stage3
5.114200E-01
Stage1-vs-Stage4
4.022600E-01
Stage2-vs-Stage3
1.957420E-01
Stage2-vs-Stage4
7.550000E-01
Stage3-vs-Stage4
1.963950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.575800E-01
Normal-vs-AfricanAmerican
3.392000E-01
Normal-vs-Asian
2.578800E-01
Caucasian-vs-AfricanAmerican
8.583600E-01
Caucasian-vs-Asian
5.540400E-01
AfricanAmerican-vs-Asian
7.704000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.502200E-01
Normal-vs-Female
2.460000E-01
Male-vs-Female
8.597200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.610200E-01
Normal-vs-Age(41-60Yrs)
2.009600E-01
Normal-vs-Age(61-80Yrs)
2.268200E-01
Normal-vs-Age(81-100Yrs)
2.560400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.167400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.122800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.860400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.464190E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.901720E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.561800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.322600E-01
Normal-vs-Daily Drinker
2.527000E-01
Normal-vs-Weekly Drinker
3.343200E-01
Normal-vs-Occasional Drinker
2.875600E-01
Normal-vs-Social Drinker
3.244800E-01
Non Drinker-vs-Daily Drinker
3.390800E-01
Non Drinker-vs-Weekly Drinker
3.583200E-01
Non Drinker-vs-Occasional Drinker
6.447800E-01
Non Drinker-vs-Social Drinker
2.382400E-01
Daily Drinker-vs-Weekly Drinker
9.347400E-01
Daily Drinker-vs-Occasional Drinker
2.266400E-01
Daily Drinker-vs-Social Drinker
7.275800E-01
Weekly Drinker-vs-Occasional Drinker
2.359000E-01
Weekly Drinker-vs-Social Drinker
8.241800E-01
Occasional Drinker-vs-Social Drinker
1.684170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.543200E-01
Normal-vs-Grade 2
9.287500E-02
Normal-vs-Grade 3
9.208000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.768200E-04
Grade 1-vs-Grade 3
3.196900E-03
Grade 1-vs-Grade 4
2.543200E-01
Grade 2-vs-Grade 3
8.653000E-01
Grade 2-vs-Grade 4
9.287500E-02
Grade 3-vs-Grade 4
9.208000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.794000E-01
Normal-vs-NonDiabetic
2.652000E-01
Diabetic-vs-NonDiabetic
4.876200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.125900E-02
Normal-vs-NoPancreatitis
3.009000E-01
Pancreatitis-vs-NoPancreatitis
5.955200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.537400E-01
Normal-vs-N1
2.207000E-01
N0-vs-N1
1.031400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.746580E-01
Normal-vs-TP53-NonMutant
7.449200E-01
TP53-Mutant-vs-TP53-NonMutant
1.69334999999826E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
